Page results
-
This page provides information about anaesthesia for children having proton beam therapy.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
This page explains what vaginal dilation therapy is and includes a step-by-step guide to how it should be performed. If you have any questions, please talk to your healthcare team.
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
-
Information on parvovirus for patients with haemolytic anaemias.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
File results
-
FOI/2021/0516 - Number of patients arriving at UCLH via ambulance
-
FOI/2021/0517 - Guideline/ Treatment pathway of Chronic Kidney Disease (CKD)
-
FOI/2021/0520 - Policy for gestational diabetes testing
-
FOI/2021/0521 - Policies and approach on the NHS Accessible Information Standard (AIS)
-
FOI/2021/0524 - Maternal death cases (2005 - 2015)
-
FOI/2021/0529 - Radiology department e-mail system for patients to reschedule appointments
-
FOI/2021/0531 - Neonatal care unit complaints over limited access due to Covid-19 restrictions
-
FOI/2021/0536 - PAT Testing
-
FOI/2021/0537 - Clinical waste information
-
FOI/2021/0538 - Treatment for triple-negative breast cancer